These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. The potential of trace amines and their receptors for treating neurological and psychiatric diseases. Berry MD Rev Recent Clin Trials; 2007 Jan; 2(1):3-19. PubMed ID: 18473983 [TBL] [Abstract][Full Text] [Related]
4. Peptide and trace amine orphan receptors: prospects for new therapeutic targets. Davenport AP Curr Opin Pharmacol; 2003 Apr; 3(2):127-34. PubMed ID: 12681233 [TBL] [Abstract][Full Text] [Related]
5. Targeting neuroinflammation with brain penetrant P2X7 antagonists as novel therapeutics for neuropsychiatric disorders. Bhattacharya A; Ceusters M Neuropsychopharmacology; 2020 Jan; 45(1):234-235. PubMed ID: 31477815 [No Abstract] [Full Text] [Related]
6. MicroRNAs as CNS Drug Targets. Gurwitz D Drug Dev Res; 2016 Nov; 77(7):331-335. PubMed ID: 27569840 [No Abstract] [Full Text] [Related]
7. A renaissance in trace amines inspired by a novel GPCR family. Lindemann L; Hoener MC Trends Pharmacol Sci; 2005 May; 26(5):274-81. PubMed ID: 15860375 [TBL] [Abstract][Full Text] [Related]
8. The impact of metabotropic glutamate receptors into active neurodegenerative processes: A "dark side" in the development of new symptomatic treatments for neurologic and psychiatric disorders. Bruno V; Caraci F; Copani A; Matrisciano F; Nicoletti F; Battaglia G Neuropharmacology; 2017 Mar; 115():180-192. PubMed ID: 27140693 [TBL] [Abstract][Full Text] [Related]
9. The dopamine D2 receptor: new surprises from an old friend. Bonci A; Hopf FW Neuron; 2005 Aug; 47(3):335-8. PubMed ID: 16055058 [TBL] [Abstract][Full Text] [Related]
10. Update 1 of: Recent progress in development of dopamine receptor subtype-selective agents: potential therapeutics for neurological and psychiatric disorders. Ye N; Neumeyer JL; Baldessarini RJ; Zhen X; Zhang A Chem Rev; 2013 May; 113(5):PR123-78. PubMed ID: 23464812 [No Abstract] [Full Text] [Related]
11. Trace amines: identification of a family of mammalian G protein-coupled receptors. Borowsky B; Adham N; Jones KA; Raddatz R; Artymyshyn R; Ogozalek KL; Durkin MM; Lakhlani PP; Bonini JA; Pathirana S; Boyle N; Pu X; Kouranova E; Lichtblau H; Ochoa FY; Branchek TA; Gerald C Proc Natl Acad Sci U S A; 2001 Jul; 98(16):8966-71. PubMed ID: 11459929 [TBL] [Abstract][Full Text] [Related]
12. Biogenic amines and their metabolites in body fluids of normal, psychiatric and neurological subjects. Davis BA J Chromatogr; 1989 Apr; 466():89-218. PubMed ID: 2663901 [TBL] [Abstract][Full Text] [Related]
14. Toll-like receptors as potential therapeutic targets for multiple diseases. Zuany-Amorim C; Hastewell J; Walker C Nat Rev Drug Discov; 2002 Oct; 1(10):797-807. PubMed ID: 12360257 [TBL] [Abstract][Full Text] [Related]
15. The emerging roles of human trace amines and human trace amine-associated receptors (hTAARs) in central nervous system. Khan MZ; Nawaz W Biomed Pharmacother; 2016 Oct; 83():439-449. PubMed ID: 27424325 [TBL] [Abstract][Full Text] [Related]
16. Psychotherapeutic drugs and biogenic amines. Current concepts and therapeutic implications. Potter WZ Drugs; 1984 Aug; 28(2):127-43. PubMed ID: 6205841 [TBL] [Abstract][Full Text] [Related]
17. Some aspects of basic psychopharmacology: the trace amines. Boulton AA Prog Neuropsychopharmacol Biol Psychiatry; 1982; 6(4-6):563-70. PubMed ID: 6298892 [TBL] [Abstract][Full Text] [Related]
18. [Progress in chemotherapy of psychiatric diseases]. Hara T Nihon Ishikai Zasshi; 1972 Feb; 67(2):517-38. PubMed ID: 4551812 [No Abstract] [Full Text] [Related]